Vir Biotechnology, Inc. VIR Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$442.72M-1.1% | -$437.99M+12.3% | -$499.65M+9.2% | -$550.23M+4.7% | -$577.65M-10.7% | ||
| $11.62M-0.5% | $11.68M+0.1% | $11.67M+0.9% | $11.57M-10.4% | $12.91M-11.3% | ||
| $47.1M-4.0% | $49.07M-8.6% | $53.71M-9.0% | $59.05M-14.1% | $68.76M-12.4% | ||
| —— | —— | —— | $8.61M+375% | -$3.14M-218% | ||
| —— | —— | -$68.1M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$7.85M-6.5% | -$7.37M+58.2% | -$17.64M+5.8% | -$18.73M+9.8% | -$20.76M+9.9% | ||
| -$446.05M-13.9% | -$391.78M+13.6% | -$453.54M+0.9% | -$457.45M-10.2% | -$415.08M+7.0% | ||
| $3.59M-25.6% | $4.83M-25.4% | $6.48M-27.4% | $8.93M+26.5% | $7.06M-3.3% | ||
| $871.01M-1.7% | $886.33M+12.0% | $791.37M+3.2% | $767.07M-9.3% | $846.09M-31.5% | ||
| $1.07B-10.9% | $1.2B+3.6% | $1.16B-4.6% | $1.22B-16.0% | $1.45B-16.7% | ||
| $195.39M-37.0% | $310.37M-14.8% | $364.46M-17.7% | $442.61M-26.0% | $597.77M+19.7% | ||
| $163.7M+12,035% | $1.35M-6.1% | $1.44M+2.1% | $1.41M+147% | $569K-28.0% | ||
| $165.71M+4,278% | $3.79M-5.6% | $4.01M+1.8% | $3.94M-18.5% | $4.83M+10.2% | ||
| —— | —— | -$85.07M— | —— | —— | ||
| -$5.78M+39.0% | -$9.47M+6.1% | -$10.09M-10.5% | -$9.13M+1.3% | -$9.25M-71.4% | ||
| —— | —— | —— | —— | —— | ||
| $9.65M-16.6% | $11.57M-37.5% | $18.51M-9.8% | $20.52M+51.7% | $13.53M-4.4% | ||
| —— | —— | -$68.1M— | —— | —— | ||
| -$7.85M-6.5% | -$7.37M+58.2% | -$17.64M+5.8% | -$18.73M+9.8% | -$20.76M+9.9% | ||
| $18.19M+43.8% | $12.64M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $5.2M+4.4% | $4.98M+4.8% | $4.75M+1.4% | $4.69M-4.8% | $4.92M-6.2% | ||
| $1.07B-10.9% | $1.2B+3.6% | $1.16B-4.6% | $1.22B-16.0% | $1.45B-16.7% | ||
| —— | —— | $2.82M+1.1% | $2.79M-10.7% | $3.12M-7.5% | ||
| —— | —— | —— | —— | —— | ||
| -$7.85M-6.5% | -$7.37M+58.2% | -$17.64M+5.8% | -$18.73M+9.8% | -$20.76M+9.9% | ||
| -$449.64M-13.4% | -$396.61M+13.8% | -$460.02M+1.4% | -$466.38M-10.5% | -$422.14M+6.9% | ||
| -$449.64M-13.4% | -$396.61M+13.8% | -$460.02M+1.4% | -$466.38M-10.5% | -$422.14M+6.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Vir Biotechnology, Inc. generate?
- Vir Biotechnology, Inc. (VIR) generated -$446.1M in operating cash flow over the trailing twelve months.
- What is Vir Biotechnology, Inc.'s free cash flow?
- After $3.6M of capital expenditures, Vir Biotechnology, Inc.'s free cash flow was -$449.6M over the trailing twelve months, down 6.5% year over year.
- Where does Vir Biotechnology, Inc.'s cash flow data come from?
- Every line is extracted from Vir Biotechnology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
